The main goals of chronic obstructive pulmonary disease (COPD) management include treatment of symptoms and prevention of exacerbations. Current guidelines recommend use of one or more long-acting ...

Time to first exacerbation was significantly longer with tiotropium. Both inhaled long-acting β-agonists and inhaled anticholinergic agents are first-line treatments for patients with ...

A generic fluticasone-salmeterol (Wixela Inhub) maintenance inhaler was clinically equivalent to name-brand Advair Diskus for chronic obstructive pulmonary disease (COPD), a propensity score-matched ...

Initiation of fluticasone propionate–salmeterol after a COPD-related hospitalization or ED visit decreased the risk of a recurrent event and reduced COPD-related medical costs. Objectives: To quantify ...

The Towards a Revolution in COPD Health (TORCH) trial evaluated the effect of treatments for chronic obstructive pulmonary disease (COPD) on morbidity and mortality outcomes. The study randomized ...

This cost-utility analysis compares the cost-effectiveness of salmeterol, fluticasone propionate, combination salmeterolfluticasone, and no maintenance therapy in chronic obstructive pulmonary disease ...

Salmeterol (Serevent) and formoterol (Foradil Aerolizer) are two long-acting beta2-agonists that are FDA-approved for maintenance treatment of chronic obstructive pulmonary disease (COPD), including ...

ZURICH, Sept 20 (Reuters) - Novartis' lung drug Onbrez Breezhaler allows patients with a deadly lung disease to breathe more easily than a current mainstay treatment, adding to positive sentiment ...

Managing asthma or COPD means using proven medications, being mindful with supplements, and making lifestyle choices that ...

Please provide your email address to receive an email when new articles are posted on . Fluticasone-based inhaled corticosteroid treatment substantially changed airway microbiome diversity in patients ...